P1218: FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA

• X. Chen,
• Y. Ping,
• L. Li,
• L. Zhang,
• X. Zhang,
• J. Huang,
• M. Sersch,
• Z. Wang,
• D. Song,
• H. Wang,
• L. Shen,
• W. Zhao,
• H. Zhang,
• M. Zhang,
• Y. Zhang

Affiliations

X. Chen

1 The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Y. Ping

2 The First Affiliated Hospital of Zhengzhou University, Zhengzhou

L. Li

2 The First Affiliated Hospital of Zhengzhou University, Zhengzhou

L. Zhang

2 The First Affiliated Hospital of Zhengzhou University, Zhengzhou

X. Zhang

2 The First Affiliated Hospital of Zhengzhou University, Zhengzhou

J. Huang

2 The First Affiliated Hospital of Zhengzhou University, Zhengzhou

M. Sersch

3 Gracellbiotechnologies Ltd

Z. Wang

4 Gracell Biotechnologies Ltd, Shanghai, China

D. Song

4 Gracell Biotechnologies Ltd, Shanghai, China

H. Wang

4 Gracell Biotechnologies Ltd, Shanghai, China

L. Shen

4 Gracell Biotechnologies Ltd, Shanghai, China

W. Zhao

4 Gracell Biotechnologies Ltd, Shanghai, China

H. Zhang

4 Gracell Biotechnologies Ltd, Shanghai, China

M. Zhang

2 The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Y. Zhang

2 The First Affiliated Hospital of Zhengzhou University, Zhengzhou